Jim Lebenthal

He hates to say this, but the world will remain a violent place. 

A definite hold, though you can probably add to it here. It reports Thursday and he wants to hear how the streaming business is going, and are the theme parks recovering. A lot of things 

It reports tomorrow. It's a pricey stock, but it's also growing like a weed. People love their shoes. Volumes are up.

A very cyclical company in construction materials. Lower interest rates should help the flagging housing industry. Benefits from infrastructure spending and have reported good numbers recently.

He added more AbbVie. Obviously, today's news about the disappointing drug trials is not good. This schizophrenia drug was projected to make $1.1 billion in sales four years from now. But today's share plunge is too great, overdone. He might add on even more weakness. Trades at 14x forward PE and pays a 3.9% dividend. It's a great company on sale. They have a long track record of making acquisitions.

Consider seasonality: there will be money managers playing catch up by throwing money at names like this. So, NVDA is likely to go higher along with the market.

When the company announce Apple Intelligence, shares surged, based on the expectation of a super-cycle upgrade. But this is not happening. Also, shares are vulnerable at a low-30s PE. But automatically, passive flows go into Apple.

He's the most interested in this name among the megatechs. Yes, regulatory issues and fines, but the real question is whether Perplexity is eating into GOOG's search business. If no, then GOOG is very cheap.

He bought it because he wanted defence exposure. Unfortunately, the world will demand defense (Middle East, Ukraine, BRIC). LMT's order book for fighter jets is strong. He bought a small position, because the valuation is high--he bit the bullet. He will add on weakness. Their last report showed signs of life in the margins, now that supply chain problems are gone.

He sold it because of problems with one of their engines. That was a mistake. They solved that issue and demand for defence remains. A good company.

Some brands like ON and Skechers are hot, and some like Nike are not. You must pick your spots in this sector.

Management has replaced key drug, Humira, and made key acquisitions. Are doing all the right things.

Is hitting a new high today because oil prices are high. XOM's earnings are down this year, because those prices are down. He can't say that oil prices are definitely rising, but OPEC sees demand rising through 2050. There's a lot of room for prices to go higher.

A good insurer that will benefit from them raising premiums.

They report Tuesday. Lots of moving parts now, but overall demand remains high. The problem in recent months is overcapacity in the airline industry.